Illumina and ACT are aligned in supporting patient health and outcomes. Illumina’s mission is to improve human health by unlocking the power of the genome. Their focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.
Illumina’s Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Illumina has funded an incredible £40,000 to ACT to provide essential care packs to families whose children have been admitted to Addenbrooke’s in an emergency.
Not only did Illumina provide this vital funding but their staff also volunteered to create and deliver the packs to the hospitals.
Addenbrooke’s often has children admitted from outside the region with their parents, and these emergency care packs will make a huge difference to families during their stay. The first packs were being used the same day the team delivered them, highlighting how important they are.
Thank you Illumina for your continued support in helping to improve care at the hospital!
“Our mission is to improve human health by unlocking the power of the genome. We are passionate about breaking down barriers for patients and accelerating access to genomics. Patient support and experience is an integral part of the care journey, which is why we are honoured to partner with ACT.“
Mark Robinson, VP and GM, UK and Ireland, Illumina